| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/20/2011 | EP1592423B1 Combination therapy of zd6474 with 5-fu and/or cpt-11 |
| 04/20/2011 | EP1569657B1 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
| 04/20/2011 | EP1546100B1 New benzoyl piperidine compounds |
| 04/20/2011 | EP1532149B9 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | EP1399161B1 Sustained-release analgesic compounds |
| 04/20/2011 | EP1392319B1 Hypotensive lipid (prostaglandin) and timolol compositions and methods of using same |
| 04/20/2011 | EP1385993B1 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 04/20/2011 | EP1313752B1 Methods for synthesizing nucleoside derivatives |
| 04/20/2011 | EP1292592B1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 04/20/2011 | CN1993323B Indole, indazole or indoline derivatives |
| 04/20/2011 | CN1990470B Phthiobuzonum derivative, its manufacturing process, pharmaceutical combination and uses thereof |
| 04/20/2011 | CN1985833B Use of estrone derivative EA204 in preparing vascular smooth muscle relaxant |
| 04/20/2011 | CN1955183B 20-bit esterified camptothecine derivate, its preparation method and drug composite and use |
| 04/20/2011 | CN1946384B Statins for the treatment of ocular hypertension and glaucoma |
| 04/20/2011 | CN1935131B Pharmaceutical use of 1 beta-hydroxy ilexolic acid for inhibiting hepatitis virus |
| 04/20/2011 | CN1930190B Hyaluronic acid derivative and drug containing the same |
| 04/20/2011 | CN1927212B Application of resveratrol glycoside in preparation of drug for treating Parkinson disease |
| 04/20/2011 | CN1915978B Crystal form of lonidamine, preparation method, and composition of containing the crystal form |
| 04/20/2011 | CN1909929B Anti-inflammatory analgesic for external use |
| 04/20/2011 | CN1901896B Use of selected amino acid-zinc complexes as anti-malarials |
| 04/20/2011 | CN1882353B Sialogogue and oral composition and food composition containing same |
| 04/20/2011 | CN1875953B Percutaneous absorption-type pharmaceutical preparation |
| 04/20/2011 | CN1872107B Chinese and Western compound preparations of alpha receptor blocking pharmacon, preparation method, and application |
| 04/20/2011 | CN1854130B Chinazoline derivative, its production, medicinal composition and use |
| 04/20/2011 | CN1839866B Medicinal composition containing breviscapine |
| 04/20/2011 | CN1836667B Eye drop |
| 04/20/2011 | CN1834095B Nonnucleoside antivirus inhibitor, its preparation method and use |
| 04/20/2011 | CN1830445B Composition of tropane derivatives having therapy use and polymorph thereof |
| 04/20/2011 | CN1824647B Crystal of (+-)2-(dimethylamino)-1-{[o-(m-methoxyphenethyl)phenoxy]methyl}ethyl hydrogen succinate hydrochloride |
| 04/20/2011 | CN1785189B Method for quality control of compounding metformin glipidide |
| 04/20/2011 | CN1771949B Soft nimodipine capsule and its preparation |
| 04/20/2011 | CN1730475B Aromatic amine ketene compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 04/20/2011 | CN1698620B Cucurbitacin emulsion capable of filtering out and eliminating bacteria and preparation method thereof |
| 04/20/2011 | CN1628179B Detection of hepatocellular carcinoma |
| 04/20/2011 | CN102027113A MicroRNA (MIRNA) and downstream targets for diagnostic and therapeutic purposes |
| 04/20/2011 | CN102026999A Azetidine and cyclobutane derivatives as JAK inhibitors |
| 04/20/2011 | CN102026998A Spirocyclic derivatives as histone deacetylase inhibitors |
| 04/20/2011 | CN102026996A Pyridazine derivatives as factor XIA inhibitors |
| 04/20/2011 | CN102026995A 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 04/20/2011 | CN102026994A Crystal of benzimidazole compound |
| 04/20/2011 | CN102026993A New compounds III |
| 04/20/2011 | CN102026992A Novel HSP inhibitory carbazole derivatives, compositions containing same, and use thereof |
| 04/20/2011 | CN102026990A Novel inhibitors of hepatitis c virus replication |
| 04/20/2011 | CN102026989A Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease |
| 04/20/2011 | CN102026988A 3-substituted propanamine compounds |
| 04/20/2011 | CN102026987A Therapeutic agent for pain |
| 04/20/2011 | CN102026986A Hexafluoroisopropanol derivatives |
| 04/20/2011 | CN102026985A Quinazoline derivatives as RAF kinase modulators and methods of use thereof |
| 04/20/2011 | CN102026983A Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
| 04/20/2011 | CN102026980A Isoquinolinone derivatives as NK3 antagonists |
| 04/20/2011 | CN102026978A Pyridine compounds |
| 04/20/2011 | CN102026976A Morpholine derivates as antiobesity agents |
| 04/20/2011 | CN102026975A Piperazines as anti-obesity agents |
| 04/20/2011 | CN102026974A Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 04/20/2011 | CN102026973A 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor |
| 04/20/2011 | CN102026972A New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 04/20/2011 | CN102026969A Novel N-(2-amino-phenyl)-acrylamides |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102026667A Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 04/20/2011 | CN102026665A Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer |
| 04/20/2011 | CN102026664A Composition for stabilizing Beta-blocker, and transdermally absorbable preparation comprising the composition |
| 04/20/2011 | CN102026642A A composition for regulation cellular senescence comprising lysophosphatidic acid and inhibitor of adenylyl cyclase as active ingredients |
| 04/20/2011 | CN102026641A Pharmaceutical preparation comprising DPP-IV inhibitor and other diabetes therapeutic agent in concomitant or combined form |
| 04/20/2011 | CN102026640A sGC stimulators, sGC activators and combinations thereof for the treatment of hearing impairment |
| 04/20/2011 | CN102026639A 3-hydroxy gepirone for the treatment of attention deficit disorder and sexual dysfunction |
| 04/20/2011 | CN102026638A A combination drug for treating vascular disorder |
| 04/20/2011 | CN102026637A Lipoprotein lipase-activating compositions comprising benzene derivates |
| 04/20/2011 | CN102026636A Oxymethylene aryl compounds and uses thereof |
| 04/20/2011 | CN102026635A Pharmaceutical compositions for the treatment of warts |
| 04/20/2011 | CN102026634A Induction of tumor hypoxia for cancer therapy |
| 04/20/2011 | CN102026633A 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 04/20/2011 | CN102026632A Emollient composition |
| 04/20/2011 | CN102026631A Emollient composition for the preventive treatment of atopic dermatitis |
| 04/20/2011 | CN102026629A Transdermally absorbable preparation |
| 04/20/2011 | CN102026628A Oral controlled release tablet with reduced burst effect |
| 04/20/2011 | CN102026627A Orally-disintegrating solid preparation |
| 04/20/2011 | CN102026626A Granulate comprising escitalopram oxalate |
| 04/20/2011 | CN102026625A Dithiocarbamate metal chelates and methods of making and using thereof |
| 04/20/2011 | CN102026624A Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant |
| 04/20/2011 | CN102026623A Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 04/20/2011 | CN102026618A Parenteral formulations of dopamine agonists |
| 04/20/2011 | CN102026616A Substances that increase the activation threshold of immune cells |
| 04/20/2011 | CN102026544A Macrocyclic tetrazolyl hepatitis c serine protease inhibitors |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102020765A Preparation methods of poly (aspartic acid-co-lactic acid) graft polymer and nanoparticles of poly (aspartic acid-co-lactic acid) graft polymer |
| 04/20/2011 | CN102020689A 1,2-trans rhamnose indican derivative of anthone compounds and preparation method thereof |
| 04/20/2011 | CN102020671A Preparation and application of 3,7,10-trimethyl-silatrane Schiff base derivatives |
| 04/20/2011 | CN102020660A Antofloxacin hydrochloride crystallization mode, preparation method and medical composition comprising same |
| 04/20/2011 | CN102020657A Condensed heteroaryl derivative, and preparation method and application thereof |
| 04/20/2011 | CN102020653A New application of amino perhydrogenated quinazoline compound and derivative preparation thereof for improving drug effects of anticancer drugs |
| 04/20/2011 | CN102020651A 6-aryl amino pyridone formamide MEK (methyl ethyl ketone) inhibitor |
| 04/20/2011 | CN102020649A Diketopiperazine compound as well as composition, preparation method and application thereof |
| 04/20/2011 | CN102020648A 3-aryl-6-aryl-[1,2,4] triazol [4,3-b] pyridazine taken as cell proliferation inhibitor and application of cell proliferation inhibitor |
| 04/20/2011 | CN102020646A Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 04/20/2011 | CN102020645A Pyrazolopyrimidinone derivatives and pharmaceutical salts, preparation method and application thereof |
| 04/20/2011 | CN102020643A dihydropteridine ketone derivative, and preparation method and medicinal application thereof |
| 04/20/2011 | CN102020640A Tetrahydroindolone and tetrahydroindolone derivative as well as preparation method and medical application thereof |
| 04/20/2011 | CN102020639A 6-amido quinazoline or 3-cyano quinoline derivative, preparation method thereof and application of derivative to medicament |